NCT05155644View on ClinicalTrials.gov

Safety of Therapeutic Step-down in Neuromyelitis Optica

CompletedOBSERVATIONAL
Enrollment

947

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Neuromyelitis Optica
Trial Locations (1)

67091

Service de Neurologie - Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT05155644 - Safety of Therapeutic Step-down in Neuromyelitis Optica | Biotech Hunter | Biotech Hunter